Researchers identify a blood biomarker linked to worse outcomes in diffuse cutaneous systemic sclerosis, paving the way for early detection and treatment.
Kristel Tjandra
Advertisement
Kristel Tjandra is a writer for the Yale School of Medicine Editorial Department.
Articles by Kristel Tjandra
Advertisement
Latest Updated Articles
Test Could Help Identify Patients at Risk for Severe SclerodermaPublished: April 9th 2025 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
